The World Health Organisation’s approval for emergency use listing (EUL) of Bharat Biotech’s Covaxin is expected to take a few more weeks to arrive. The decision, however, will be taken in October itself. WHO’s Strategic Advisory Group of Experts on Immunisation (SAGE) is holding its meetings from October 4 to 8, during which it will examine the latest evidences to prepare policy recommendations for the best use of Covaxin. The policy guidelines will be issued once the EUL process is completed.
from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/3uJfaxy
from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/3uJfaxy
Comments
Post a Comment